| Dr Andrew Michael Dubois, MD | |
|
395 Northside Dr, Batesville, IN 47006-7012 | |
| (812) 932-2387 | |
| (812) 222-0104 |
| Full Name | Dr Andrew Michael Dubois |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 395 Northside Dr, Batesville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518097237 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forefront Dermatology | 3779471701 | 474 |
| Forefront Dermatology | 3779471701 | 474 |
News Archive
Anadys Pharmaceuticals, announced today that dosing has begun in the Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin in hepatitis C patients.
A Norwegian study shows that general practitioners in Norway show little competency in understanding different cultures. Researcher Esperanza Diaz at the University of Bergen asks for mandatory training.
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended March 31, 2012.
"On Monday, N2Care, a company formed by a Methodist minister in Salem, Va., showed off its first MedCottage, a 12-by-24-foot prototype filled with biometric technology that would allow a family and health-care providers to monitor the condition of an aging or disabled relative. … [T]he Virginia General Assembly this year passed legislation, HB1307, that supersedes local zoning laws and allows families to install such a dwelling on their property with a doctor's order."
› Verified 7 days ago
| Entity Name | Forefront Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659796225 PECOS PAC ID: 3779471701 Enrollment ID: O20140425001640 |
News Archive
Anadys Pharmaceuticals, announced today that dosing has begun in the Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin in hepatitis C patients.
A Norwegian study shows that general practitioners in Norway show little competency in understanding different cultures. Researcher Esperanza Diaz at the University of Bergen asks for mandatory training.
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended March 31, 2012.
"On Monday, N2Care, a company formed by a Methodist minister in Salem, Va., showed off its first MedCottage, a 12-by-24-foot prototype filled with biometric technology that would allow a family and health-care providers to monitor the condition of an aging or disabled relative. … [T]he Virginia General Assembly this year passed legislation, HB1307, that supersedes local zoning laws and allows families to install such a dwelling on their property with a doctor's order."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Michael Dubois, MD 801 York St, Manitowoc, WI 54220-4630 Ph: (866) 630-9882 | Dr Andrew Michael Dubois, MD 395 Northside Dr, Batesville, IN 47006-7012 Ph: (812) 932-2387 |
News Archive
Anadys Pharmaceuticals, announced today that dosing has begun in the Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin in hepatitis C patients.
A Norwegian study shows that general practitioners in Norway show little competency in understanding different cultures. Researcher Esperanza Diaz at the University of Bergen asks for mandatory training.
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended March 31, 2012.
"On Monday, N2Care, a company formed by a Methodist minister in Salem, Va., showed off its first MedCottage, a 12-by-24-foot prototype filled with biometric technology that would allow a family and health-care providers to monitor the condition of an aging or disabled relative. … [T]he Virginia General Assembly this year passed legislation, HB1307, that supersedes local zoning laws and allows families to install such a dwelling on their property with a doctor's order."
› Verified 7 days ago